Bayer gets first approval for stroke drug asundexian
Bayer's oral Factor XIa inhibitor asundexian has been cleared in its first market, China, for secindary stroke prevention.
ESMO26: AZ's claudin ADC doubles survival in GI cancers
AstraZeneca's CLARITY-Gastric01 trial of sone-ve in CLDN18.2-positive gastrointestinal cancers reveals a 53% reduction in the risk of death.
UK biotech financing shoots up, setting up "a record year"
UK biotech shrugged off a difficult economic environment with a 44% increase in venture capital investment in the third quarter to £270m, says BIA.
ESMO26: Roche's KRAS drug tops approved drugs in NSCLC
In the Krascedo-1 trial, Roche's KRAS G12C inhibitor divarasib met high expectations, with a head-to-head win over Lumakras and Krazati.
UK puts £100m into "world-first" AI biosecurity facility
The UK government will unveil a big investment package in AI in the Budget this week, headlined by £100m in funding for an AI Biosecurity Lab.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
31st Edition Strategic Project & Portfolio Management for Ph...
The Marcus Evans 31st Edition Strategic Project & Portfolio Management for Pharma conference, for European pharmaceutical PMO and portfolio leaders.
Women in AI - an evening of practical AI learning
Women in AI returns November 10 in London, UK. Join women from across healthcare for an evening of practical AI learning.
UAE investment drives Middle East biopharma transformation a...
Exclusive analysis for World Health Expo (WHX) by Frost & Sullivan forecasts precision medicine growth of more than 10% in the Middle East over the ne
Europe's Largest Gathering for ADC Innovation
Taking place in London from 8-11 March 2027, the 17th World ADC London returns as Europe's largest annual gathering dedicated to the ADC community
PharmaMarketing Summit 2027 to Convene America's Top Pharmac...
Elite industry leaders will gather to address AI-driven engagement, launch excellence, and the future of market access at an exclusive, invitation-only event